Company Summary - Advanced Medical Solutions Group PLC (LSE:AMS)
31.50p
0.25p
(-0.79%)
FTSE AIM All Share Health Care Equipment & ServicesMarket cap: £45.170m
Review a company's summary page in more detail and see the key fundamentals at a glance. Sign-up to Premium now to make your investment decisions.
Sign-up to Premium's Free 7 Day trial See an improved company summary
Summary
Design, development, manufacture and distribution of novel high performance polymers (both natural and synthetic) for use in advanced woundcare dressings and materials and medical adhesives for closing and sealing tissue for sale into the global medical device market
| Financials - Interim (9/9/2008) | ||
|---|---|---|
| Turnover | £m | 9.84 |
| Pre-tax Profit | £m | 1.2 |
| EPS | p | 0.84 |
| DPS | p | 0.00 |
| Director | Board Role |
|---|---|
| Dr. Geoffrey Vernon | Chairman |
| Dr. Don Evans | Chief Executive |
| Mary Tavener | Finance Director & Company Sec |
Products Brands & Subsidiaries
Products & Brands
Fenistil; Flexipore; Merfen; Mitraflex; Replicare; Savlon ActivHeal; Spyroflex; Trofolastin(R) Scar Reduction
Subsidiaries
Advanced Medical Solutions Ltd; Advanced Medical Solutions (UK) Ltd; MedLogic Global Holdings Ltd...
Free Annual Reports
The PrecisionIR Group Annual Reports Service provides you with quick access to annual reports and other information on selected companies.
Broker Sentiment (3 brokers)
| Heading | Date |
|---|---|
| Holding(s) in Company | 22/12/2008 |
| Total Voting Rights | 19/12/2008 |
| Trading Update | 17/12/2008 |